 |
|
|
| |
IMPROVED METABOLIC PARAMETERS AFTER SWITCHING FROM TAF-BASED 3- OR 4-DRUG REGIMEN TO THE 2-DRUG REGIMEN OF DTG/3TC (DOLUTEGRAVIR/LAMIVUDINE):
THE TANGO STUDY
|
| |
| |
- increased odds of metabolic syndrome at Week 48 were observed for female participants and those with hypertension, high triglycerides, low HDL, and HOMA-IR ≥4 at baseline
IAC 2020 July 26 Virtual
Reported by Jules Levin
Jean van Wyk,1 Mounir Ait-Khaled,1 Jesus Santos,2 Stefan Scholten,3 Michael Wohlfeiler,4 Faiza Ajana,5 Bryn Jones,1 Maria Claudia Nascimento,1 Allan Tenorio,6 Don E. Smith,7 Jonathan Wright,8 Brian Wynne6
1ViiV Healthcare, Brentford, UK; 2Hospital Virgen de la Victoria, Málaga, Spain; 3Praxis Hohenstaufenring, Cologne, Germany;
4AIDS Healthcare Foundation, Miami Beach, FL, USA; 5Centre Hospitalier de Tourcoing, Tourcoing, France; 6ViiV Healthcare,
Research Triangle Park, NC, USA; 7Albion Centre, Sydney, Australia; 8GlaxoSmithKline, Stockley Park, UK
|
| |
|
|
|
|
|
